These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. RECENT TRENDS IN THE MEDICAL TREATMENT OF HYPERTENSION. BECKWITH JR; CAMP JL; MOSCA A Va Med Mon (1918); 1964 Oct; 91():435-42. PubMed ID: 14217036 [No Abstract] [Full Text] [Related]
4. CARDIOVASCULAR RENAL AGENTS AS THEY IMPINGE ON OPHTHALMIC PRACTICE. HARRIS JE Invest Ophthalmol; 1964 Oct; 3():481-8. PubMed ID: 14229932 [No Abstract] [Full Text] [Related]
5. [PROBLEMS OF ANESTHESIA IN PATIENTS UNDER TREATMENT OF HYPERTENSION]. HUEGIN W Anaesthesist; 1963 Sep; 12():280-5. PubMed ID: 14051294 [No Abstract] [Full Text] [Related]
6. [SEVERE NEUROLOGICAL SIDE-EFFECTS IN HYPOTENSION THERAPY]. BOETTIGER LE; MALMBORG RO; MICHAELI EW Nord Med; 1964 Apr; 71():523-5. PubMed ID: 14131560 [No Abstract] [Full Text] [Related]
7. RECENT ADVANCES AND TRENDS IN DRUG THERAPY. 3. HYPOTENSIVE AGENTS. ROWE WS Med J Aust; 1964 Nov; 2():804-6. PubMed ID: 14221991 [No Abstract] [Full Text] [Related]
9. Differential effect of hypotensive drugs on renal and steroid hypertensive rats. Willard PW; Beckhelm GA Arch Int Pharmacodyn Ther; 1968 May; 173(1):11-5. PubMed ID: 5657813 [No Abstract] [Full Text] [Related]
10. TOXICITY OF HYPOTENSIVE DRUGS. WILSON GM Practitioner; 1965 Jan; 194():51-5. PubMed ID: 14259691 [No Abstract] [Full Text] [Related]
11. Fourteen-year survival in a case of malignant hypertension under hypotensive drug therapy. Pomerantz HZ Can Med Assoc J; 1968 Nov; 99(21):1043-7. PubMed ID: 5721944 [No Abstract] [Full Text] [Related]
12. THE CHOICE OF HYPOTENSIVE AGENTS. PALMER KN Practitioner; 1964 Jul; 193():43-9. PubMed ID: 14194585 [No Abstract] [Full Text] [Related]
13. [GUANETHIDINE. A NEW TYPE HYPOTENSIVE DRUG]. RIPKA O; MALIS F Cas Lek Cesk; 1963 Nov; 102():1286-91. PubMed ID: 14117811 [No Abstract] [Full Text] [Related]
15. [GUANETHIDINE (ISMELIN) AND BRETYLIUM (DARENTHIN)--NEW HYPOTENSIVE DRUGS]. KADZIELAWA K Postepy Hig Med Dosw; 1964; 18():489-510. PubMed ID: 14260337 [No Abstract] [Full Text] [Related]
16. THE PLACE OF METHYLDOPA IN THE TREATMENT OF SEVERE HYPERTENSION. CONWAY J; ZWEIFLER AJ; JULIUS S JAMA; 1963 Oct; 186():266-8. PubMed ID: 14057121 [No Abstract] [Full Text] [Related]
17. [Clinical and experimental studies on the hypotensive effect of guanethidine]. LICHTLEN P; SCHAUB F; BUEHLMANN A Dtsch Med Wochenschr; 1960 Jul; 85():1249-57. PubMed ID: 13761922 [No Abstract] [Full Text] [Related]
18. [Methyl-dopa and mebutamate. Hypotensive action of guanethidine. Comparative study]. PERRICONI H; DEL RIO CA; MAZZEI CM Prensa Med Argent; 1963 Jan; 50():53-60. PubMed ID: 13942574 [No Abstract] [Full Text] [Related]
19. [A new hypotensive drug: guanethidine. Its association with the hydralazines]. BRICAUD H; DALLOCCHIO M; SAUTRON J; BROUSTET P Presse Med (1893); 1961 Dec; 69():2683-5. PubMed ID: 13873008 [No Abstract] [Full Text] [Related]
20. [Medical therapy of arterial hypertension]. Dalla Volta S Cardiol Prat; 1968 Oct; 19(5):357-67. PubMed ID: 5733216 [No Abstract] [Full Text] [Related] [Next] [New Search]